Ecolab Inc. (ECL) said that it has entered into an agreement with AvidBiotics Corp. under which they will jointly work to develop a new technology that could significantly reduce the presence of the pathogen E. coli O157:H7 in red meat products.
The companies' intent is to successfully commercialize AvidBiotics' proprietary protein-based antibacterial technology, which can be targeted against specific bacterial pathogens. While this platform technology may be applicable to numerous food pathogens, the companies are first targeting the food pathogen E. coli in red meat.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.